Dual-Sampling Attention Network for Diagnosis of COVID-19 From Community Acquired Pneumonia.

Journal: IEEE transactions on medical imaging
Published Date:

Abstract

The coronavirus disease (COVID-19) is rapidly spreading all over the world, and has infected more than 1,436,000 people in more than 200 countries and territories as of April 9, 2020. Detecting COVID-19 at early stage is essential to deliver proper healthcare to the patients and also to protect the uninfected population. To this end, we develop a dual-sampling attention network to automatically diagnose COVID-19 from the community acquired pneumonia (CAP) in chest computed tomography (CT). In particular, we propose a novel online attention module with a 3D convolutional network (CNN) to focus on the infection regions in lungs when making decisions of diagnoses. Note that there exists imbalanced distribution of the sizes of the infection regions between COVID-19 and CAP, partially due to fast progress of COVID-19 after symptom onset. Therefore, we develop a dual-sampling strategy to mitigate the imbalanced learning. Our method is evaluated (to our best knowledge) upon the largest multi-center CT data for COVID-19 from 8 hospitals. In the training-validation stage, we collect 2186 CT scans from 1588 patients for a 5-fold cross-validation. In the testing stage, we employ another independent large-scale testing dataset including 2796 CT scans from 2057 patients. Results show that our algorithm can identify the COVID-19 images with the area under the receiver operating characteristic curve (AUC) value of 0.944, accuracy of 87.5%, sensitivity of 86.9%, specificity of 90.1%, and F1-score of 82.0%. With this performance, the proposed algorithm could potentially aid radiologists with COVID-19 diagnosis from CAP, especially in the early stage of the COVID-19 outbreak.

Authors

  • Xi Ouyang
  • Jiayu Huo
  • Liming Xia
    From the Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands (Q.T., E.H.M.P., D.P.S., A.d.R., H.J.L., R.J.v.d.G.); Department of Electrical Engineering, Fudan University, Shanghai, China (W.Y., Y.W.); Multidisciplinary Cardiovascular Research Centre & Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, England (P.G., S.P.); Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (L.H., L.X.); and Departments of Cardiology (M.S.) and Radiology (J.T.), Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Fei Shan
    Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
  • Jun Liu
    Department of Radiology, Second Xiangya Hospital, Changsha, Hunan, China.
  • Zhanhao Mo
  • Fuhua Yan
    Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No.197 Ruijin Er Road, Shanghai 200025, China. Electronic address: yfh11655@rjh.com.cn.
  • Zhongxiang Ding
  • Qi Yang
    Department of Radiology, The First Hospital of Jilin University, No.1, Xinmin Street, Changchun 130021, China (Y.W., M.L., Z.M., J.W., K.H., Q.Y., L.Z., L.M., H.Z.).
  • Bin Song
    Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Feng Shi
    Department of Research and Development, Shanghai United Imaging Intelligence, Co., Ltd. Shanghai, China.
  • Huan Yuan
  • Ying Wei
    School of Information Science and Engineering, Northeastern University, Shenyang 110004, China ; Key Laboratory of Medical Imaging Calculation of the Ministry of Education, Shenyang 110004, China.
  • Xiaohuan Cao
    School of Automation, Northwestern Polytechnical University, Xi'an, China.
  • Yaozong Gao
  • Dijia Wu
  • Qian Wang
    Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun, China.
  • Dinggang Shen
    School of Biomedical Engineering, ShanghaiTech University, Shanghai, China.